Head and Neck Cancer News & Features
A prospective study found that patients with human papillomavirus-related disease had better treatment response than HPV-negative patients.
Patients with allergic rhinitis may have an increased risk of developing nasopharyngeal carcinoma.
A majority of patients enrolled in a phase 1 trial of CUDC-101 were found to be free progression at 1.5 years of median follow-up, according to a published report.
Investigators have uncovered genomic differences, with potentially important clinical implications, in head and neck cancers caused by infection with the human papillomavirus.
Significant benefits of exercise regimen in reducing the effect of percutaneous endoscopic gastrostomy placement on swallowing function for patients with head and neck cancer.
Head and Neck Cancer Clinical Trials
- Study may support active surveillance for favorable intermediate-risk prostate cancer
- New mechanism of acquired resistance to breast cancer drugs discovered
- Two major studies strengthen case for prostate cancer drug before chemotherapy
- Finding a qualified acupuncture practitioner
- New opportunity to treat drug-resistant leukemia discovered
- High-cost blood cancer drugs deliver high value
- Statins increase risk of diabetes in Caucasian men
- Sun damage predisposes pediatric patients to melanoma
- Risk of reproductive cancers increased in daughters of women who smoked during pregnancy
- Older white males with advanced bladder cancer more likely to commit suicide
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|